- iRhythm Technologies (IRTC, Financial) released its 2024 Corporate Sustainability Report, emphasizing its commitment to quality and sustainability.
- The report focuses on key areas including technological innovation, global expansion, workforce and inclusion, and environmental impact.
- Significant achievements include a 89.5% waste diversion rate, ISO 14001:2015 certification, and regulatory approval for expansion into new markets.
iRhythm Technologies, Inc. (IRTC), a leader in digital health care solutions, has published its 2024 Corporate Sustainability Report. This reveals the company’s strides in promoting a sustainable and inclusive future through its focus on technological innovation, health equity, workforce development, and environmental stewardship.
Key accomplishments cited in the report include enhancements in quality systems, improved Electronic Health Record (EHR) integration, securing strategic licensing agreements, and establishing an AI Governance Committee. These initiatives reflect iRhythm’s commitment to advancing connected patient care and addressing AI-related challenges and opportunities.
In terms of global expansion, iRhythm successfully launched operations in four European countries—Austria, the Netherlands, Spain, and Switzerland—and obtained regulatory approval from the Japanese authorities for its Zio® 14-day ECG monitoring system, enhancing its access to international markets.
The report also highlights efforts in workforce and inclusion, such as refreshing core corporate values, revising the code of conduct, and implementing recognition programs to celebrate employees aligning with company ethics and culture.
On the environmental front, iRhythm completed a comprehensive inventory of Scope 3 greenhouse gas emissions and achieved an impressive 89.5% landfill waste diversion rate. Additionally, the company was awarded the ISO 14001:2015 Environmental Management certification and was featured in Newsweek’s list of America’s Greenest Companies for 2025.
iRhythm Technologies continues to lead in developing solutions that translate data from wearable biosensors into actionable insights for better health outcomes, supporting their mission of delivering better data, better insights, and better health for all.
